Glenmark Looks To Chronic Diseases

To read the full article, please choose one of the following options:

Possibly encouraged by signs that non-communicable chronic diseases such as diabetes and cancer are on the rise in Africa, Glenmark Pharmaceuticals Nigeria, a subsidiary of India's Glenmark Pharmaceuticals has announced the expansion of its product range. In 2000, almost half the burden of disease was due to non-communicable diseases in low and middle-income countries - a proportion that is set to rise over the coming years as infectious disease control is improved and Western lifestyles become more